Heat shock protein inducer modifies arrhythmogenic substrate and inhibits atrial fibrillation in the failing heart.
暂无分享,去创建一个
Satoshi Higa | Shih‐Ann Chen | Yi‐Jen Chen | Y. Kao | Y. Lai | H. Yeh | Chiao-Po Hsu | Yao-Chang Chen | Yung-Kuo Lin | S. Chang | S. Chang
[1] Shih‐Ann Chen,et al. Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium. , 2012, Clinical science.
[2] Shih‐Ann Chen,et al. Heart Failure Enhanced Pulmonary Vein Arrhythmogenesis and Dysregulated Sodium and Calcium Homeostasis with Increased Calcium Sparks , 2011, Journal of cardiovascular electrophysiology.
[3] L. Lai,et al. Mechanical stretch of atrial myocyte monolayer decreases sarcoplasmic reticulum calcium adenosine triphosphatase expression and increases susceptibility to repolarization alternans. , 2011, Journal of the American College of Cardiology.
[4] Barry Greenberg,et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.
[5] Shih‐Ann Chen,et al. Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes. , 2010, Journal of molecular and cellular cardiology.
[6] W. Rappel,et al. Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. , 2008, Journal of the American College of Cardiology.
[7] S. Nattel,et al. Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia. , 2008, Cardiovascular research.
[8] T. Shimada,et al. Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72. , 2007, Journal of molecular and cellular cardiology.
[9] I. V. Van Gelder,et al. Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation , 2006, Circulation research.
[10] I. V. Van Gelder,et al. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. , 2006, Journal of molecular and cellular cardiology.
[11] H. Ballard,et al. Further study on the role of HSP70 on Ca2+ homeostasis in rat ventricular myocytes subjected to simulated ischemia. , 2006, American journal of physiology. Cell physiology.
[12] E. Kranias,et al. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. , 2005, Cardiovascular research.
[13] Alan Garfinkel,et al. Electrical Restitution and Cardiac Fibrillation , 2002, Journal of cardiovascular electrophysiology.
[14] T. Sakata,et al. Single Oral Dose of Geranylgeranylacetone Induces Heat-Shock Protein 72 and Renders Protection Against Ischemia/Reperfusion Injury in Rat Heart , 2001, Circulation.
[15] I. Scheffler,et al. Combined and Individual Mitochondrial HSP60 and HSP10 Expression in Cardiac Myocytes Protects Mitochondrial Function and Prevents Apoptotic Cell Deaths Induced by Simulated Ischemia-Reoxygenation , 2001, Circulation.
[16] D. McMillan,et al. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. , 1998, Circulation research.
[17] A. Mattiazzi,et al. Immunodetection of Phosphorylation Sites Gives New Insights into the Mechanisms Underlying Phospholamban Phosphorylation in the Intact Heart* , 1996, The Journal of Biological Chemistry.
[18] K. Rokutan,et al. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. , 1996, Gastroenterology.
[19] S. Cobbe,et al. Comparison of in vivo and in vitro haemodynamic function in experimental heart failure: use of echocardiography. , 1996, Cardiovascular research.
[20] M R Franz,et al. New classification of moricizine and propafenone based on electrophysiologic and electrocardiographic data from isolated rabbit heart. , 1994, Journal of cardiovascular pharmacology.
[21] E. Carafoli,et al. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum , 1989, Nature.
[22] M R Franz,et al. Current status of monophasic action potential recording: theories, measurements and interpretations. , 1999, Cardiovascular research.